Home administration of lanreotide Autogel® by patients with acromegaly, or their partners, is safe and effective

OBJECTIVE: The introduction of ready-to-use lanreotide Autogel® has presented the possibility of patients receiving their acromegaly treatment at home. The objective of this study was to assess the ability of patients (or their partners) to administer repeat, unsupervised, injections of lanreotide A...

Descripción completa

Detalles Bibliográficos
Autores principales: Bevan, J S, Newell-Price, J, Wass, J A H, Atkin, S L, Bouloux, P M, Chapman, J, Davis, J R E, Howlett, T A, Randeva, H S, Stewart, P M, Viswanath, A
Formato: Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2008
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2268964/
https://www.ncbi.nlm.nih.gov/pubmed/17892497
http://dx.doi.org/10.1111/j.1365-2265.2007.03044.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2268964/
https://www.ncbi.nlm.nih.gov/pubmed/17892497
http://dx.doi.org/10.1111/j.1365-2265.2007.03044.x

Ejemplares similares